首页> 外文OA文献 >PIN99 Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial: Results from Four Major Cities in China

【2h】

PIN99 Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial: Results from Four Major Cities in China

机译：利奈唑胺和万古霉素治疗耐甲氧西林金黄色葡萄球菌（MRSA-NP）引起的医院内肺炎的PIN99成本-效果分析（CEA）基于IV期临床试验：来自中国四个主要城市的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wan Y.; Wang X.; Wu B.; Kang H.; Li Q.; Chen Y.; Li J.Z.; Liu S.; Gao X.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Characterization of Methicillin-Resistant Staphylococcus aureus Strains Recovered from a Phase IV Clinical Trial for Linezolid versus Vancomycin for Treatment of Nosocomial Pneumonia [J] . Rodrigo E. Mendes, Lalitagauri M. Deshpande, Davida S. Smyth, Journal of Clinical Microbiology . 2012,第11期

机译：从利奈唑胺与万古霉素治疗院内肺炎的IV期临床试验中回收的耐甲氧西林金黄色葡萄球菌菌株的特性
2. The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus : data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin [J] . Ozlem Equils, Christopher da Costa, Michele Wible, BMC Infectious Diseases . 2016,第1期

机译：糖尿病对耐甲氧西林金黄色葡萄球菌引起的院内肺炎患者预后的影响：一项前瞻性双盲临床试验的数据，比较了利奈唑胺和万古霉素的治疗
3. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. [J] . Mullins CD, Kuznik A, Shaya FT, Clinical therapeutics . 2006,第8期

机译：利奈唑胺与万古霉素治疗因耐甲氧西林的金黄色葡萄球菌引起的医院内肺炎的成本效益分析。
4. Characterization of Methicillin-Resistant Staphylococcus aureus Strains Recovered from a Phase IV Clinical Trial for Linezolid versus Vancomycin for Treatment of Nosocomial Pneumonia [O] . Rodrigo E. Mendes, Lalitagauri M. Deshpande, Davida S. Smyth, 2012

机译：从利奈唑胺与万古霉素治疗院内肺炎的IV期临床试验中回收的耐甲氧西林金黄色葡萄球菌菌株的特性
5. PIN64 Cost-Effectiveness Analysis Of Linezolid Versus Vancomycin In The Treatment Of Nosocomial Pneumonia Caused By Methicillin Resistant Staphylococcus Aureus (Mrsa) Based On A Phase 4 Clinical Trial [O] . Li J., Li J.Z., Gao X., 2013

机译：基于第4期临床试验的利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌（Mrsa）引起的医院内肺炎的PIN64成本-效果分析

PIN99 Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial: Results from Four Major Cities in China

著录项

引文网络

相似文献

相关主题

期刊订阅